We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKAM icon
301
Akamai
AKAM
$15.6B
$6.19M 0.04%
56,875
+709
+1% +$81.7K
SRE icon
302
Sempra
SRE
$58.1B
$6.12M 0.04%
85,163
-225,025
-73% -$16.1M
ALV icon
303
Autoliv
ALV
$9.14B
$6.08M 0.04%
50,478
+7,872
+18% +$881K
EVH icon
304
Evolent Health
EVH
$371M
$6.07M 0.04%
185,228
+6,565
+4% +$209K
AKRO
305
DELISTED
Akero Therapeutics
AKRO
$6.06M 0.04%
240,000
+56,000
+30% +$1.35M
SNOW icon
306
Snowflake
SNOW
$98.1B
$6.03M 0.04%
37,319
-37,860
-50% -$7.34M
EWTX icon
307
Edgewise Therapeutics
EWTX
$4.28B
$6M 0.04%
329,000
+21,000
+7% +$334K
ONT
308
Onterris Inc
ONT
$731M
$6M 0.04%
153,099
+3,449
+2% +$116K
AXSM icon
309
Axsome Therapeutics
AXSM
$11.7B
$5.99M 0.04%
75,084
-10,000
-12% -$839K
APGE icon
310
Apogee Therapeutics
APGE
$10.1B
$5.98M 0.04%
+90,000
New +$3.93M
TMCI icon
311
Treace Medical Concepts
TMCI
$262M
$5.94M 0.04%
454,945
+104,945
+30% +$1.4M
RHI icon
312
Robert Half
RHI
$4.11B
$5.93M 0.04%
16,274
+3,466
+27% +$279K
HUBB icon
313
Hubbell
HUBB
$24.4B
$5.91M 0.04%
14,247
+7,803
+121% +$2.82M
NEO icon
314
NeoGenomics
NEO
$1.96B
$5.9M 0.04%
375,017
+170,010
+83% +$2.62M
CRBU icon
315
Caribou Biosciences
CRBU
$146M
$5.89M 0.04%
1,145,063
+285,039
+33% +$1.76M
HHH icon
316
Howard Hughes
HHH
$3.94B
$5.88M 0.04%
84,946
+41,757
+97% +$3.1M
USB icon
317
US Bancorp
USB
$97.9B
$5.81M 0.04%
129,894
-255,010
-66% -$10.8M
GPCR icon
318
Structure Therapeutics
GPCR
$3.37B
$5.79M 0.04%
135,000
-75,000
-36% -$3.16M
FDX icon
319
FedEx
FDX
$73B
$5.67M 0.04%
19,576
+1,578
+9% +$395K
MPC icon
320
Marathon Petroleum
MPC
$90.1B
$5.62M 0.04%
27,888
-28
-0.1% -$4.79K
OMC icon
321
Omnicom Group
OMC
$22.7B
$5.61M 0.04%
57,931
+43,239
+294% +$3.88M
NWSA icon
322
News Corp Class A
NWSA
$15.6B
– –
0
– –
BHVN icon
323
Biohaven
BHVN
$2.02B
$5.47M 0.04%
+100,000
New +$4.95M
EXPD icon
324
Expeditors International
EXPD
$22.3B
$5.43M 0.03%
44,650
+17,727
+66% +$2.19M
EHC icon
325
Encompass Health
EHC
$11.3B
$5.37M 0.03%
64,984
+2,304
+4% +$169K
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.